Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

UCB identifies antiepileptic compounds improving on padsevonil

May 10, 2021

Gut microbiome affects protein folding in brain, muscles

May 7, 2021

Pivotal trial of arimoclomol in ALS does not meet primary and secondary endpoints

May 7, 2021

CB-5083 ameliorates disease pathology in VCP-mutated knock-in mouse model of IBMPFD

May 7, 2021

Pipeline Therapeutics synthesizes muscarinic M1 receptor antagonists

May 6, 2021

Study identifies four Alzheimer's subtypes

May 6, 2021

SOM-3355 reduces chorea in patients with HD

May 5, 2021

Betacellulin is a novel therapeutic target in schizophrenia

May 5, 2021

Proof of concept demonstrated with ABX-002 prodrug brain delivery of thyromimetic LL-340001

May 5, 2021

Prime, base editing are "finer scalpels" in dystrophy

May 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...